Latest financial market updates and expert analysis
Analysis In the competitive landscape of metabolic disease therapeutics, Biomea Fusion is attracting increased investor attention. As industry giants continue to dominate the GLP-1 therapy segment, market participants are looking toward...
Shares of Social Media Venture are currently trapped in a prolonged state of informational silence. Trading on the speculative over-the-counter...
A sharp weekly decline in India’s benchmark indices, the steepest in over a year, placed significant pressure on the VanEck...
Medical technology firm Bioventus concluded its 2025 fiscal year with robust fourth-quarter performance, surpassing analyst consensus on key financial metrics....
In a notable shift, CFRA Research has upgraded its rating on Netflix shares to “Buy,” assigning a $115 price target....
After a period of significant gains, Barrick Gold Corporation is confronting a sobering reality. The mining giant is not only...
The coming weeks represent a critical period for Mountain Province Diamonds, as a series of imminent financial obligations will test...
Biotechnology firm Ocugen has announced significant progress across its pipeline targeting inherited retinal diseases, alongside its latest financial results. The...
The global sportswear leader Nike is tightening its operational controls. In a bid to enhance efficiency and bolster profitability, the...
Facing a prolonged and severe downturn, the former high-flyer of the plant-based meat sector, Beyond Meat, is executing a dramatic...
After a challenging year that saw its value decline significantly, shares of The Trade Desk experienced a sharp reversal on...
